Trials / Completed
CompletedNCT00368303
A Local Register Study For Major Depression Of Paroxetine Controlled Release
A Multicentre, Double-blind, Active Controlled Trial to Evaluate the Clinical Effects of Immediate Release Paroxetine and Controlled Release Paroxetine in the Treatment of Major Depression
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 362 (planned)
- Sponsor
- GlaxoSmithKline · Industry
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
The study is to investigate the non-inferior efficacy of Paroxetine Controlled Release to Paroxetine Immediate Release, as well as the drug tolerability profile when treated on patients with Major Depression.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Paroxetine CR | |
| DRUG | Paroxetine IR |
Timeline
- Start date
- 2006-12-01
- First posted
- 2006-08-24
- Last updated
- 2012-06-04
Locations
11 sites across 1 country: China
Source: ClinicalTrials.gov record NCT00368303. Inclusion in this directory is not an endorsement.